YW
Yin Wu
King's College London, Royal College of Physicians, University College London, University of Cambridge
Research areas: Medicine · Oncology · Cancer Immunotherapy and Biomarkers · T-cell and B-cell Immunology · Cutaneous Melanoma Detection and Management
0000-0003-4080-3935
Employment
Education
-
Royal College of Physicians MRCP (UK)? - 2013
-
University College London MBBS (MBPhD)? - 2010
-
University College London PhD (MBPhD)? - 2009
- ? - 2004
Projects & Funding
-
Human gamma delta T cells: from fundamental biology to cancer immunotherapy Wellcome Trust Ltd2026 - 2034
-
Investigating the contribution of gamma-delta T-cells to immunosurveillance of cancer and response to immunotherapy Wellcome Trust2021 - 2026
-
Identifying critical pathways regulating autoimmunity in immuno-oncology and arthritis patients. Short title: IPADS (Immune PAthways for Drug Side-effects) Cancer Research UK2018 - 2020
-
Identifying critical pathways regulating autoimmunity in immuno-oncology and arthritis patients. (IPADS) Versus Arthritis2018 - 2018
-
Investigating the immmune regulation of non-small cell lung cancer by gamma-delta T-cells Academy of Medical Sciences2018 - 2020
Publications (31)
- Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies Save
- γδ T cells modulate anti-tumor immunity in small cell lung cancer Save
- Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy Save
- Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma Save
- PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy Save
- IFN-γ–dependent interactions between tissue-intrinsic γδ T cells and tissue-infiltrating CD8 T cells limit allergic contact dermatitis Save
- Quantifying the impact of immunotherapy on RNA dynamics in cancer Save
- Local γδ T cells: translating promise to practice in cancer immunotherapy Save
- The Effects of Clonal Heterogeneity on Cancer Immunosurveillance Save
- Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers Save
- Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood Save
- Impact of cancer evolution on immune surveillance and checkpoint inhibitor response Save
- Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19 Save
- A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer Save
- Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant Save
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Save
- Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients Save
- A dynamic COVID-19 immune signature includes associations with poor prognosis Save
- An innate-like Vδ1 + γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer Save
- A clonal expression biomarker associates with lung cancer mortality Save